KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Debt (2016 - 2026)

Amgen has reported Total Debt over the past 18 years, most recently at $57.3 billion for Q1 2026.

  • For Q1 2026, Total Debt changed 0.1% year-over-year to $57.3 billion; the TTM value through Mar 2026 reached $57.3 billion, changed 0.1%, while the annual FY2025 figure was $54.6 billion, 9.14% down from the prior year.
  • Total Debt for Q1 2026 was $57.3 billion at Amgen, up from $54.6 billion in the prior quarter.
  • Over five years, Total Debt peaked at $64.6 billion in Q4 2023 and troughed at $36.5 billion in Q2 2022.
  • A 5-year average of $54.5 billion and a median of $57.4 billion in 2025 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: soared 68.51% in 2023 and later dropped 10.37% in 2025.
  • Year by year, Total Debt stood at $38.9 billion in 2022, then soared by 65.91% to $64.6 billion in 2023, then decreased by 6.99% to $60.1 billion in 2024, then fell by 9.14% to $54.6 billion in 2025, then rose by 4.98% to $57.3 billion in 2026.
  • Business Quant data shows Total Debt for AMGN at $57.3 billion in Q1 2026, $54.6 billion in Q4 2025, and $54.6 billion in Q3 2025.